Article History
Accepted: 31 March 2022
First Online: 9 May 2022
Competing interests
: D.G.G. is on the Board of Directors and equity holder at LabCorp and Nuvalent. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and until 31 August 2020 was a Scientific Advisory Board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and ThermoFisher Scientific; and since 1 August 2020 is an employee of Genentech, a member of the Roche Group and has Roche stock. E.E.S. is Founder, Chief Executive Office (CEO) and Director of Sema4, and owns equity in this publicly traded company; and is also on the Board of Directors of Sage Bionetworks and 4YouAndMe, both non-profit medical research institutions. J.T. is employed by and stockholder in 23andMe.